Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Myriad Genetics (MYGN) Shares Repurchased (2016)

Myriad Genetics (MYGN) has disclosed Shares Repurchased for 7 consecutive years, with $10.3 million as the latest value for Q4 2016.

  • Quarterly Shares Repurchased fell 58.63% to $10.3 million in Q4 2016 from the year-ago period, while the trailing twelve-month figure was $10.3 million through Mar 2019, changed N/A year-over-year, with the annual reading at $50.0 million for FY2019, N/A changed from the prior year.
  • Shares Repurchased for Q4 2016 was $10.3 million at Myriad Genetics, down from $21.3 million in the prior quarter.
  • The five-year high for Shares Repurchased was $102.3 million in Q3 2013, with the low at $10.3 million in Q4 2016.
  • Average Shares Repurchased over 5 years is $45.6 million, with a median of $44.9 million recorded in 2013.
  • Peak annual rise in Shares Repurchased hit 273.36% in 2013, while the deepest fall reached 64.6% in 2013.
  • Over 5 years, Shares Repurchased stood at $33.7 million in 2012, then soared by 130.99% to $77.8 million in 2013, then fell by 25.07% to $58.3 million in 2014, then tumbled by 57.29% to $24.9 million in 2015, then tumbled by 58.63% to $10.3 million in 2016.
  • According to Business Quant data, Shares Repurchased over the past three periods came in at $10.3 million, $21.3 million, and $54.7 million for Q4 2016, Q3 2016, and Q2 2016 respectively.